Destiny Pharma Share Discussion Threads

[malcolmmm] 14/1/2021 10:12

Good daily rises ,equity development give a fair value of 265p

[okidokicoki] 12/1/2021 20:50

This share was brought to my attention firstly through Sky News on the IPO. They did quite a big segment on it so I'm sure they will big it up if the results are good in a month or 2 . Somebody with alot of power in the mainstream media must have big interest in this company .

[supracat] 12/1/2021 17:59

Agreed. I think this will open ahead in the morning and like you say will prob move upwards quite rapidly as part of the momentum it's already started. We know that at some point in Q1 the P2b results will be announced. My guess is late Feb/early March and hopefully there is further good news in these results.

[okidokicoki] 12/1/2021 09:21

When this breaks £1 can see it moving very very quickly. Seems to move on very small volume

[neo2725] 07/1/2021 19:33

The BOD have a significant share holding and when you add in the long term holders from the inventor family trust etc I don’t see this share falling on much rather the opposite in fact. Today the share price started to run away and MMs either had to apply the breaks or we had profit takers cashing out at £1. Either way much more distance to travel with this share, especially now the trial is complete and it’s just a waiting game for the results in a month or two. Wish all my shares were this well behaved (looking at you ODX ). Happy evening all, stay safe

[supracat] 07/1/2021 12:24

You did well at 65p. I got most of mine down in the mid/high 30s then a load more in the placing too. Hold tight for an exciting ride!

[bspgamer] 07/1/2021 12:09

So pleased I grabbed 170k of these in placing

[supracat] 07/1/2021 11:59

I think it's more the intent and signals this gives out more than the amount. Seems to have helped drive activity today...

[malcolmmm] 07/1/2021 11:27

Mentioned these as a buy on ORPH board at 62p, another phama stock and was moderated, their lose. Upward and onward

[wh1spa] 07/1/2021 10:59

My l2 showing different spread to advfn1 @98 vs 1@104

[goblin99] 07/1/2021 10:52

Let's not get carried away with the director purchase, it was only a few thousand!

[supracat] 07/1/2021 10:40

Indeed. He knows some positive news coming up....These will be up over 100p by close today. ?

[kipper1960] 07/1/2021 10:25

Pleased to see the Director has had to buy at market price (88p). Too many companies dish out share options before they have been earned.

[seanlander] 07/1/2021 10:22

Closing in on the £1!

[okidokicoki] 07/1/2021 07:24

Director dealings RNS

[supracat] 06/1/2021 19:10

I get the feeing that this appointment is Pre empting a successful phase 2b and as said elsewhere her knowledge of working with a Nasdaq business previously and her undoubtedly vast network plays to Destiny's post phase 2b plans. The fact DP are moving ahead rapidly with plans suggests to me the trials went well and I'd expect to hear the results some time later in Feb, but this is just a hunch... Hopefully break through 100p by end of the week with little resistance through to 180p.

[gb904150] 06/1/2021 17:01

Stephanie Bewick looks a fantastic appointment.

That coupled with Phase 2b trial of XF-73 completing recruitment yesterday. Very positive.

Results from the Phase 2b trials expected in Q1 2021. Not long to wait. If all is OK Then on to Phase III but DEST have said that's when they'd bring in a partner.

DEST looks to have a very bright future.

[supracat] 06/1/2021 16:43

Long overdue this rally and hopefully continues right up to 150p and above.

[fillipe] 06/1/2021 16:00

DEST - 90p is the lowest ask on show.
Only 1500 shrs showing at that price and 3 then other lots of 1500 shrs at 91/92/and 94p.

No wonder it's a strong riser, although actual inquiring will no doubt elicit somewhat large amounts .... perhaps.

f

[malcolmmm] 06/1/2021 13:50

Looking good

[kipper1960] 06/1/2021 11:48

Interesting that Dr.Bewick was VP of Summit Therapeutics, a NASDAQ listed pharma. It suggests to me that DEST wanted to bring in someone with NASDAQ experience and contacts because a NASDAQ listing is planned. There will need to be a major fundraise to finance 2 sets of phase 3 clinicals (NTCD-M3 and XF-73); will get higher valuation on NASDAQ than AIM. Very exciting times for DEST

[wh1spa] 06/1/2021 09:41

Nice appointment announcement this morning- happy days

[edmonda] 06/1/2021 08:46

Full patient recruitment for Phase 2b study kicks off what should be an exciting year

Updated research from Dr Andy Smith just published by Equity Dev, with fair value still seen at 262p / share

Read full note here and see recent CEO interview on prospects:

[supracat] 05/1/2021 16:54

Hi Mike. Try this link. https://www.research-tree.com/Dashboard/DownloadResearchNote/8_25109

[mikeh30] 05/1/2021 14:13

You got a link for the 380p tp